US Plans to Appoint Two New FDA Deputy Commissioners for Tech and Drugs, CNBC Reports

HHS plans two new deputy commissioners at FDA, CNBC reports By Investing.com

HHS plans two new deputy commissioners at FDA, CNBC reports

US plans to appoint two new FDA deputy commissioners for tech and drugs, CNBC reports

The U.S. Department of Health and Human Services is planning to appoint two new deputy commissioners at the Food and Drug ​Administration, CNBC reported, citing sources familiar with the ‌matter.

HHS eyeing new FDA deputy commissioners, including one for AI

AbCellera Biologics (ABCL) stock and other AI-driven healthcare companies rise as the FDA plans to create a new deputy commissioner role for technology. Read more here.

HHS plans new FDA deputy commissioner roles for technology and drugs, sources say

HHS plans to name two deputy commissioners for technology and drugs, said two sources familiar with the matter.